diabetes by means of video consultation in an rural area particularly under the conditions of COVID-19, to evaluate long-term effects and to include a new group of patients who were previously excluded from care [...] Funded by the Ministry of Science and Culture of Lower Saxony (MWK) DIMI / COVID-19, Digital Infection Monitoring in Immunocompromised Patients Project leader: Prof. Dr. Georg Behrens / Dr. Stefanie Castell [...] have been transmitted from animals to humans and have caused two epidemics including the current COVID-19 pandemic. The treatment options against these viruses are very limited. The ways corona viruses

oncology during COVID-19 pandemic – ethical, legal and health-economic implications Project leader: Prof. Dr. Jörg Haier Department / Institute: CCC Hannover (Claudia von Schilling-Zentrum) COVID-19 pandemic [...] test, it will be possible to examine a large number of patients in clinical studies and determine how long these essential antibodies are present in the blood. In addition, the new method can be adapted so [...] available to all university hospitals, the RKI and other parties involved in the network. CODEX / COVID-19 Data Exchange Platform Project leader: Prof. Dr. med. Dr.-Ing. Michael Marschollek Department /

Rüdiger Garbs, she handed over 250 very special cultural envelopes to Dr Bastian Ringe from the COVID-19 Task Force of the Hannover Medical School (MHH). "A great idea, we thank you for this extraordinary [...] cultural institutions in Hanover that have already been struggling with the Lockdown aftermath for a long time. All participants hope that the MHH employees will be able to use the cultural envelopes as soon

Her research focusses on refugee and migrant health, health workforce in rheumatology, COVID-19 and Long COVID. Leonie Mac Fehr, MSc Team member, Research assistant fehr.leonie @ mh-hannover.de Leonie [...] important dimension of pandemic preparedness. This pilot project introduces a ‘syndemic’ approach to COVID-19 with a focus on higher-skilled; it connects health policy/system and actor-centred approaches.

for this reduced pumping capacity. 3D-Heart-2B Project Page COFONI Lower Saxony Covid-19 Research Network With the COVID-19 research network Lower Saxony (COFONI), the state of Lower Saxony is funding [...] to research active substances against SARS-CoV-2 and to investigate the causes and long-term consequences of the COVID-19 disease. Further Information

und Risikofaktoren von Long-COVID. Inn Med (Heidelb) 2022;63(8):813-818 DOI: 10.1007/s00108-022-01370-4 Original-/übers. Titel: Frequency, spectrum and risk factors of long COVID Haier J, Mayer M, Schaefers [...] COVID-19 / SARS-CoV-2 Research at the MHH On this website we present the research studies and research achievements at the MHH on COVID-19. COVID-19 / SARS-CoV-2 Research at the MHH The MHH research team [...] Kooperatives Vorgehen der Pathologie und Neuropathologie in der COVID-19-Pandemie : Deutsches Register fur COVID-19-Obduktionen (DeRegCOVID) und Deutsches Netzwerk fur Autopsien in Pandemien (DEFEAT PANDEMIcs)

analyses to explore pathophysiological mechanisms of COVID-19 and signatures that predict and cause specific outcomes and phenotypes of COVID-19 and post-COVID-19 syndrome (PCS). To this end, the project was [...] support in COVID-19 infection control and pandemic surveillance. Optimization of functions, deployment and usability together with a roll-out throughout the network will be fostered to facilitate COVID-19 infection [...] entitled "Randomized assessment of Post-COVID-Syndrome treatments (RAPID) focuses on the clinical testing of various new drugs for the treatment of Post COVID Syndrome (PCS). Several underlying mechanisms

slightly different HEV strains every year, mostly by eating infected pork. But another genotype, long suspected to be found only in rats, has now been detected in patients after organ transplantation [...] vaccines have been developed against the SARS-CoV-2 coronavirus. Effective drugs for a targeted COVID-19 treatment, on the other hand, do not yet exist. The research team led by Dr. Simon Krooss wants

by the federal government, the state of Lower Saxony, the Helmholtz Association and the HZI. "The COVID-19 pandemic has just shown us how important infection research and personalised medicine are - and [...] therapy approaches. These should then clearly define who needs to be treated particularly quickly, how long treatment should last and what happens to patients who do not respond well to treatment. The indi

vaccination were sick for fewer days thanks to the VPM1002 booster, did not have to be hospitalised for as long and had fewer fever days," emphasises the study leader. In principle, VPM1002 is effective against [...] VPM1002 booster effect "VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including COVID-19 in the Elderly: a phase III randomised, double-blind, placebo-controlled, multicenter clinical